C-Change Structure

C-Change has a 22-member Board of Directors that oversees C-Change's operations. Board members have staggered 3-year terms, so that one-third of the members are elected each year.

New Board Members are elected by the entire C-Change membership. A Nominating Committee, the majority of whose members are elected by all C-Change Members, puts together a balanced slate of candidates each year; candidates are selected from a wide representation of the public, private, and nonprofit sectors; the missions of the organizations represented within C-Change; and the representative population groups bearing the greatest cancer burden.

C-Change functions like a virtual "town hall meeting", where distinguished national leaders concerned about the disease come together as a united force at least twice a year to discuss major cancer-related issues. Individual C-Change Members, for whom a particular priority area has special interest or relevance, can then coalesce into smaller issue-driven teams that act together to address the pressing opportunities, barriers, and challenges before them. Individual nongovernmental Members, on their own, may choose to lobby on behalf of federal, state, or local legislation regulation; or administrative rules. However, C-Change as a whole does not engage in lobbying activities.

Leadership

Senator Dianne Feinstein, Honorary Vice Chair
William Winkenwerder, MD, MBA Board Chair

C-Change Board of Directors provides overall leadership for C-Change's affairs.

	William Winkenwerder, MD, MBA, Chair The Winkenwerder Company		Elizabeth Duke, PhD School of Public Policy University of Maryland
	LaSalle Leffall, Jr., MD, FACS Emeritus Member Howard University Cancer Center		Lloyd Everson, MD Life Beyond Cancer Foundation
	James Marks, MD, MPH, Emeritus Member Robert Wood Johnson Foundation		Philip Huang, MD, MPH Austin/Travis County Health and Human Services Department
	John Seffrin, PhD, Emeritus Member American Cancer Society		Tom Kean, MPH C-Change
	Marguerite Baxter, RN, MN Senior Vice President CareMetx		Stephen Kindred, MD, MPH State Farm Insurance Companies
	Jean Becker Office of President George H. W. Bush		Maureen Lichtveld, MD, MPH Tulane University School of Public Health and Tropical Medicine
	Zora Brown Integris Health		Governor Ruth Ann Minner Former Governor of Delaware
	Elizabeth (Betsy) Clark, PhD, ACSW, MPH National Association of Social Workers		Martin Murphy, PhD, DMedSc CEO Roundtable on Cancer
	Robert Comis, MD Coalition of Cancer Cooperative Groups		John Niederhuber, MD Former Director, National Cancer Institute
	Robert Croyle, PhD, Federal Liaison National Cancer Institute		Amelie Ramirez, DrPH The University of Texas Health Science Center at San Antonio
	Gregory Curt, MD AstraZeneca Pharmaceuticals		Governor Bob Wise Alliance for Excellent Education

Staff

Tom Kean, MPH, President and CEO
Brian Alexander, Manager, Marketing & Information Systems
Tara Arras, CFRE, Director, Development and Major Gifts
Kinga Bartoszek, Vice President, Finance and Operations
Christopher Chester, Executive Assistant
Kristen Cox, MHPM, Manager, Strategic Initiatives
Raven Patterson, Executive Assistant 
Payal Shah, MPH, Manager, Strategic Initiatives
Alison Smith, BA, BSN, RN, Vice President for Strategic Initiatives
Brandi Stevenson, CMP, Meetings Manager
Tasha Tilghman-Bryant, MPA, Manager, Strategic Initiatives